Clinical trial
An Observational Study of Glycemic Control and Cardiovascular Outcomes Among Patients With Type 2 Diabetes Newly Initiating Glucagon-like Peptide-1 Receptor Agonists (GLP1) Versus Basal Insulin in Routine Care Settings
NCT04034524 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Study of Glycemic Control and Cardiovascular Outcomes Among Patients With Type 2 Diabetes Newly Initiating Glucagon-like Peptide-1 Receptor Agonists (GLP1) Versus Basal Insulin in Routine Care Settings
- Lead sponsor
- Brigham and Women's Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 1, 2019
- Completion date
- December 31, 2020
- Enrollment
- 20,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.